SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Stein JP, Grossfeld GD, Ginsberg DA, et al. Prognostic markers in bladder cancer: a contemporary review of the literature. J Urol. 1998; 160: 64559.
  • 2
    Mostofi FK, Sobin LH, Torlani H. Histological typing of urinary bladder tumors. International Histological Classification of Tumours. No. 10. Geneva: World Health Organization, 1973.
  • 3
    Hermanek P, Hutter RVP, Sobin LH. TNM atlas. Illustrated guide to the TNM/pTNM classification of malignant tumours. Berlin, Heidelberg: Springer-Verlag; 1997: 263326.
  • 4
    Takashi M, Murase T, Mizuno S, Hamajima N, Ohno Y. Multivariate evaluation of prognostic determinants in bladder cancer patients. Urol Int. 1987; 42: 368374.
  • 5
    Narayana AS, Loening SA, Slymen DJ, Culp DA. Bladder cancer: factors affecting survival. J Urol. 1983; 130: 5660.
  • 6
    Jahnson S, Karlsson MG. Predictive value of p53 and pRb immunostaining in locally advanced bladder cancer treated with cystectomy. J Urol. 1998; 160: 12911296.
  • 7
    Martínez-Piñeiro JA, Martínez-Piñeiro L. Tumores vesicales. In: Jiménez CruzJF, Rioja SanzLA, editors. Tratado de Urología. Barcelona: JR Prous Editores; 1993: 11511204.
  • 8
    Pfister C, Lacombe L, Vezina MC, et al. Prognostic value of the proliferative index determined by ki-67 immunostaining in superficial bladder tumors. Hum Pathol. 1999; 11: 13501355.
  • 9
    Allard P, Bernard P, Fradet Y, Têtu B. The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index. Br J Urol. 1998; 81: 692698.
  • 10
    Fujii Y, Fukui I, Kihara K, et al. Significance of bladder neck involvement on progression in superficial bladder cancer. Eur Urol. 1998; 33: 464468.
  • 11
    Kiemeney LALM, Witjes JA, Heijbroek RP, Verbeek ALM, Debruyne FMJ. Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. J Urol. 1993; 150: 6064.
  • 12
    Lipponen PK, Eskelinen MJ, Kiviranta J, Pesonen E. Prognosis of transitional cell bladder cancer: a multivariate prognostic score for improved prediction. J Urol. 1991; 146: 15351540.
  • 13
    Pycha A, Mian C, Hofbauer J, et al. Multifocality of transitional cell carcinoma results from genetic instability of entire transitional epithelium. Urology. 1999; 53: 9297.
  • 14
    Nogueira March JL. Recidivas y nuevas ocurrencias. Actas Urol Esp. 1991; 15: 211212.
  • 15
    Witjes JA, Kiemeney LALM, Schaafsma HE, Debruyne FMJ. The influence of review pathology on study outcome of a randomized multicentre superficial bladder cancer trial. Br J Urol. 1994; 73: 172176.
  • 16
    Parmar MKB, Freedman LS, Hargreave TB, Tolley DA. Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on superficial bladder cancer (Urological Cancer Working Party). J Urol. 1989; 142: 284288.
  • 17
    Mulders PFA, Meyden APM, Doesburg WH, Oosterhof GON, Debruyne FMJ. Prognostic factors in pTa-pT1 superficial bladder tumours treated with intravesical instillations. Br J Urol. 1994; 73: 403408.
  • 18
    Millán-Rodríguez F, Chéchile-Toniolo G, Salvador-Bayarri J, Palou J, Vicente-Rodríguez J. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol. 2000; 163: 7378.
  • 19
    Esrig D, Elmajian D, Groshen S, et al. Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med. 1994; 331: 12591264.
  • 20
    Tsuji M, Kojima K, Murakami Y, Kanayama H, Kagawa S. Prognostic value of Ki-67 antigen and p 53 protein in urinary bladder cancer: immunohistochemical analysis of radical cystectomy specimens. Br J Urol. 1997; 79: 367372.
  • 21
    Liukkonen T, Rajala P, Raitanen M, Rintala E, Kaasinen E, Lipponen P. Prognostic value of MIB-1 score, p53, EGFr, mitotic index and papillary status in primary superficial (Stage pTa/T1) bladder cancer: a prospective comparative study. Eur Urol. 1999; 36: 393400.
  • 22
    Schmitz-Dräger BJ, Kushima M, Goebell P, et al. p53 and MDM2 in the development and progression of bladder cancer. Eur Urol. 1997; 32: 487493.
  • 23
    Serth J, Kuczyk MA, Bokemeyer C, et al. p53 immunohistochemistry as an independent prognostic factor for superficial cell carcinoma of the bladder. Br J Cancer. 1995; 71: 201205.
  • 24
    Kuczyk MA, Bokemeyer C, Serth J, et al. p53 overexpression as a prognostic factor for advanced stage bladder cancer. Eur J Cancer. 1995; 31A: 22432247.
  • 25
    Zlotta AR, Noel JC, Fayt I, et al. Correlation and prognostic significance of p53, p21WAF1/CIP1 and ki-67 expression in patients with superficial bladder tumors treated with Bacillus Calmette-Guérin intravesical therapy. J Urol. 1999; 161: 792798.